X-155027003-C-G

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_023934.4(FUNDC2):​c.65C>G​(p.Ala22Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000241 in 1,202,283 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00012 ( 0 hom., 2 hem., cov: 23)
Exomes 𝑓: 0.000015 ( 0 hom. 3 hem. )

Consequence

FUNDC2
NM_023934.4 missense

Scores

3
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.0660
Variant links:
Genes affected
FUNDC2 (HGNC:24925): (FUN14 domain containing 2) Predicted to be involved in autophagy of mitochondrion. Located in mitochondrion. [provided by Alliance of Genome Resources, Apr 2022]
F8 (HGNC:3546): (coagulation factor VIII) This gene encodes coagulation factor VIII, which participates in the intrinsic pathway of blood coagulation; factor VIII is a cofactor for factor IXa which, in the presence of Ca+2 and phospholipids, converts factor X to the activated form Xa. This gene produces two alternatively spliced transcripts. Transcript variant 1 encodes a large glycoprotein, isoform a, which circulates in plasma and associates with von Willebrand factor in a noncovalent complex. This protein undergoes multiple cleavage events. Transcript variant 2 encodes a putative small protein, isoform b, which consists primarily of the phospholipid binding domain of factor VIIIc. This binding domain is essential for coagulant activity. Defects in this gene results in hemophilia A, a common recessive X-linked coagulation disorder. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.023335636).
BS2
High Hemizygotes in GnomAd4 at 2 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FUNDC2NM_023934.4 linkc.65C>G p.Ala22Gly missense_variant Exon 1 of 5 ENST00000369498.8 NP_076423.2 Q9BWH2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FUNDC2ENST00000369498.8 linkc.65C>G p.Ala22Gly missense_variant Exon 1 of 5 1 NM_023934.4 ENSP00000358510.3 Q9BWH2

Frequencies

GnomAD3 genomes
AF:
0.000116
AC:
13
AN:
112129
Hom.:
0
Cov.:
23
AF XY:
0.0000583
AC XY:
2
AN XY:
34299
show subpopulations
Gnomad AFR
AF:
0.000388
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000924
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000311
AC:
5
AN:
160807
Hom.:
0
AF XY:
0.0000191
AC XY:
1
AN XY:
52281
show subpopulations
Gnomad AFR exome
AF:
0.000459
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000147
AC:
16
AN:
1090154
Hom.:
0
Cov.:
31
AF XY:
0.00000840
AC XY:
3
AN XY:
357310
show subpopulations
Gnomad4 AFR exome
AF:
0.000572
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000219
GnomAD4 genome
AF:
0.000116
AC:
13
AN:
112129
Hom.:
0
Cov.:
23
AF XY:
0.0000583
AC XY:
2
AN XY:
34299
show subpopulations
Gnomad4 AFR
AF:
0.000388
Gnomad4 AMR
AF:
0.0000924
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000130
Hom.:
1
Bravo
AF:
0.000147
ExAC
AF:
0.0000498
AC:
6

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jul 26, 2024
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.65C>G (p.A22G) alteration is located in exon 1 (coding exon 1) of the FUNDC2 gene. This alteration results from a C to G substitution at nucleotide position 65, causing the alanine (A) at amino acid position 22 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.083
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-1.0
CADD
Benign
7.9
DANN
Benign
0.95
DEOGEN2
Benign
0.021
T
FATHMM_MKL
Benign
0.032
N
LIST_S2
Benign
0.39
T
M_CAP
Uncertain
0.13
D
MetaRNN
Benign
0.023
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
N
PrimateAI
Uncertain
0.58
T
PROVEAN
Benign
-0.42
N
REVEL
Benign
0.064
Sift
Benign
0.031
D
Sift4G
Uncertain
0.047
D
Polyphen
0.0
B
Vest4
0.052
MVP
0.043
MPC
0.25
ClinPred
0.019
T
GERP RS
-0.28
Varity_R
0.059
gMVP
0.12

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs782275329; hg19: chrX-154255278; API